A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria
2006

Comparing Primaquine and Bulaquine for Malaria Treatment

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): Gogtay NJ, Kamtekar KD, Dalvi SS, Mehta SS, Chogle AR, Aigal U, Kshirsagar NA

Primary Institution: Seth G.S. Medical College and K.E.M hospital

Hypothesis

Is bulaquine more effective than primaquine as a gametocytocidal agent in adults with uncomplicated falciparum malaria?

Conclusion

Bulaquine is a safe and effective alternative to primaquine for treating malaria and may clear gametocytemia faster.

Supporting Evidence

  • On day 8, 65% of primaquine recipients had gametocytes compared to 32% of bulaquine recipients.
  • All patients were gametocyte free by day 15.
  • 16 out of 31 primaquine recipients had viable gametocytes on day 8 compared to 7 out of 59 bulaquine recipients.

Takeaway

This study looked at two medicines for malaria and found that one medicine, bulaquine, works better than the other, primaquine, at getting rid of the malaria germs in the blood.

Methodology

A randomized, partial blind study comparing the effects of primaquine and bulaquine on gametocytemia in hospitalized adults with malaria.

Potential Biases

Potential bias due to unequal allocation of treatment groups and the exclusion of certain demographics.

Limitations

The study had a small sample size and excluded women, which may limit the generalizability of the results.

Participant Demographics

93 male patients aged 16-72 years, with a mean age of 31.47 years.

Statistical Information

P-Value

0.000065

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-6-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication